SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-040756
Filing Date
2020-03-31
Accepted
2020-03-31 06:03:34
Documents
12
Period of Report
2020-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2014286d1_8k.htm   iXBRL 8-K 24190
  Complete submission text file 0001104659-20-040756.txt   196829

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA srne-20200331.xsd EX-101.SCH 3222
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20200331_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20200331_pre.xml EX-101.PRE 22734
11 EXTRACTED XBRL INSTANCE DOCUMENT tm2014286d1_8k_htm.xml XML 3490
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 20759425
SIC: 2836 Biological Products, (No Diagnostic Substances)